Additionally, digoxin treatment demonstrated significant associations with the clinical outcomes including DAS28-CRP, CDAI, SDAI, and morning stiffness, suggesting that it is associated with a reduction in disease activity and symptom severity, indicating its potential beneficial role in RA patients (Table 7). Here, CRP is linked to rheumatoid arthritis.